Table of Contents
Subcommittee Report: Orally Inhaled and Nasal Drug Products (OINDP)
Draft OINDP Guidance
Main BA/BE Guidance Issues
In Vitro BA/BE Questions To the OINDP Subcommittee (26 April 2000 Meeting)
Profile Analysis
PPT Slide
Profile Analysis
Profile Analysis
In Vitro Tests for DPIs: Comparability
In Vitro Tests for DPIs: Comparability
In Vitro Tests for DPIs: Comparability
In Vivo BA/BE Questions To the OINDP Subcommittee (26 April 2000 Meeting)
Clinical Studies for Local Delivery of Nasal Aerosols and Sprays
Nasal Corticosteroid Dose-Response (e.g., Mometasone Furoate Nasal Spray)
Clinical Studies for Local Delivery of Nasal Aerosols and Sprays
Clinical Studies for Local Delivery of Nasal Aerosols and Sprays
Clinical Studies for Local Delivery of Nasal Aerosols and Sprays
Clinical Studies for Local Delivery of Nasal Aerosols and Sprays
Clinical Studies for Local Delivery of Nasal Aerosols and Sprays
Clinical Studies for Local Delivery of Orally Inhaled Corticosteroids (ICS)
Clinical Studies for Local Delivery of ICS
Clinical Studies for Local Delivery of ICS
PK or PD Studies for Systemic Exposure of Locally Acting Drugs
PK or PD Studies for Systemic Exposure of Locally Acting Drugs
Acknowledgments
PPT Slide
PPT Slide
|